Lineage, Inc.
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Derivative instruments and hedging activities
(10)Derivative instruments and hedging activities
(a)Risk management objective of using derivatives
The Company manages certain economic risks, including interest rate, foreign currency, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and with the use of derivative financial instruments.
(b)Cash flow hedges of interest rate and foreign currency risk
The Company’s objectives in using interest rate derivatives are to manage its exposure to interest rate movements and to mitigate the potential volatility to interest expense. To accomplish this objective, the Company primarily uses interest rate swaps and caps as part of its interest rate risk management strategy. Interest rate swaps involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps involve the receipt of variable amounts from a counterparty if interest rates rise above the strike rate on the contract in exchange for a premium.
In addition, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future cash amounts due to changes in foreign currency rates. The impacts of these foreign currency derivative instruments on the condensed consolidated financial statements of the Company are insignificant.
(c)Designated hedges - interest rate contracts
As of September 30, 2025, the Company had the following effective interest rate derivatives that were designated as cash flow hedging instruments.
| Number of Instruments · Notional · Effective Date · Maturity Date | |||||
|---|---|---|---|---|---|
| Interest rate derivatives: · (in millions) | |||||
| Interest rate swap | 2 | USD | 700 | May 31, 2023 | December 31, 2025 |
| Interest rate swap | 1 | USD | 300 | August 9, 2024 | December 31, 2025 |
| Interest rate cap | 3 | USD | 1,500 | January 9, 2023 | January 9, 2026 |
| Forward-starting interest rate swap | 3 | USD | 750 | January 9, 2026 | February 15, 2028 |
| Forward-starting interest rate swap | 2 | USD | 500 | December 31, 2025 | February 15, 2028 |
The table below presents the effect of the Company’s interest rate derivatives that are designated as hedging instruments in the condensed consolidated statements of operations and comprehensive income (loss) (in millions). Gain (loss)
reclassified from accumulated other comprehensive income (“AOCI”) into earnings for interest rate contracts is presented in Interest expense, net.
| Interest Rate Derivatives in Cash Flow Hedging Relationships · Amount of Gain (Loss) Recognized in OCI on Derivatives · Amount of Gain (Loss) Reclassified from AOCI into Earnings | ||||
|---|---|---|---|---|
| Three Months Ended September 30, | Three Months Ended September 30, | |||
| 2025 | 2024 | 2025 | 2024 | |
| Included in effectiveness testing | $3 | $(26) | $19 | $26 |
| Excluded from effectiveness testing and recognized in earnings based on an amortization approach | — | 1 | — | — |
| Total | $3 | $(25) | $19 | $26 |
| Interest Rate Derivatives in Cash Flow Hedging Relationships · Amount of Gain (Loss) Recognized in OCI on Derivatives · Amount of Gain (Loss) Reclassified from AOCI into Earnings | ||||
|---|---|---|---|---|
| Nine Months Ended September 30, | Nine Months Ended September 30, | |||
| 2025 | 2024 | 2025 | 2024 | |
| Included in effectiveness testing | $7 | $17 | $57 | $77 |
| Excluded from effectiveness testing and recognized in earnings based on an amortization approach | — | (2) | — | (1) |
| Total | $7 | $15 | $57 | $76 |
The estimated net amount of existing gains (losses) that are reported in Accumulated other comprehensive income (loss) as of September 30, 2025 that is expected to be reclassified into earnings within the next 12 months is $20 million.
On September 9, 2025, the Company executedtwo forward-starting interest rate swaps with an aggregate notional amount of $500 million. The swaps have an effective date of December 31, 2025 and a maturity date of February 15, 2028. The swaps have fixed interest rates ranging from 3.10% to 3.11%. The Company has designated these swaps as an effective cash flow hedge of the variable-rate exposure arising from the portion of the Term Loan A equal to the notional balance.
On June 30, 2025, the Company executed three forward-starting interest rate swaps with an aggregate notional amount of $750 million. The swaps have an effective date of January 9, 2026 and a maturity date of February 15, 2028. The swaps have fixed interest rates ranging from 3.19% to 3.20%. The Company has designated these swaps as an effective cash flow hedge of the variable-rate exposure arising from the portion of the Revolving Credit Facility equal to the notional balance.
(d)Balance sheet presentation - interest rate contracts
The table below presents the fair value of the Company’s interest rate derivative contracts as well as their classification in the condensed consolidated balance sheets:
| (in millions) | September 30, 2025 | December 31, 2024 |
|---|---|---|
| Prepaid expenses and other current assets | $20 | $— |
| Other assets | $— | $69 |
| Other long-term liabilities | $(1) | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.